(Senior) Medical Director, Medical Science
Rapport Therapeutics
| Company | Rapport Therapeutics |
| Category | Healthcare |
| Location | 99 High Street |
| Remote | On-site (inferred) |
| Employment | Not stated |
| Level | Director |
| Salary | Not stated by the employer |
| Posted | 20 May 2026 |
| Last verified | 9 Aug 2026 |
| Source | Employer ATS (greenhouse) |
Description
When our people share why they joined Rapport and love it here, it comes down to three things: the science, the mission, and the team. At Rapport, we’re driven by a passion for developing precision neuromedicines with the potential for fewer side effects, enabling patients and their families to enjoy healthier, more fulfilling lives. And we’re doing this with extraordinary science and awesome people (affectionately called Rapptors).
Our innovative scientific platform is centered on Receptor Associate Proteins (RAPs). RAPs are a component of neuronal receptor complexes, which play a crucial role in regulating receptor assembly and function. This precision approach has the potential to revolutionize the development of small molecule therapies. We are excited about the potential of our lead program, RAP-219. Our first indication targets focal epilepsy with additional clinical trials for neuropathic pain and bipolar disorder.
The strength of Rapport comes from our Rapptors – who are united by our mission to improve patients lives. We bring the heart and hustle to advance our science forward, always staying true to our core values. We hope you’re as excited about this opportunity as we are! Your Impact:
This Medical Director role offers the opportunity to partner closely with cross-functional leaders to support both clinical development and strategic initiatives in support of the RAP-219 Epilepsy program. The position provides broad exposure to multiple programs, with the chance to work hands-on in the details while growing within a fast-paced, innovative organization.
Your Day-to-Day:
Provision of medical input for all clinical deliverables in Rapport’s lead program, RAP-219, related to epilepsy
Driving execution of the assigned clinical program and/or clinical trial in partnership with clinical operations
Contributing to the development of regulatory documents in support of regulatory submissions, including the clinical sections of INDs and CTAs, safety reports, responses to regulatory authorities and Ethics Committees/IRBs, and other documents as appropriate
Ensuring that scientific rigor and innovation is at the forefront our Rapport’s clinical development strategy and implementation
Managing engagements with external organizations, key opinion leaders, and advisors
Supporting medical input into clinical development strategy and protocol reviews
Working closely with functional partners (Clinical Operations, Data Management, Biostatistics, Regulatory, Medical Affairs) to ensure an integrated and strategic approach to flawless execution and systematic oversight of study protocols
Establishing strong collaborations with study investigators and outside medical experts and representing Rapport during investigator meetings and advisory boards
Serving as the medical monitor for assigned studies including design, execution, cleaning, and interpretation of study data
Must-Haves:
MD or equivalent medical degree is required
Minimum of 2 years’ experience working in the biotech/pharmaceutical industry in clinical research or drug development
Strongly preferred advanced knowledge and clinical training and/or drug development experience in Neurology
Proven clinical development strategist with hands-on experience of designing, implementing, and conducting clinical trials in neurology, Phase 2a – Phase 3
Working knowledge of epilepsy is required, with proven ability to interpret, discuss and present efficacy and safety data relating to clinical trial(s) and proven ability to understand and interpret basic and clinical scientific research reports
Demonstrated ability to assimilate clinical data, perform thorough analysis and review, make crisp assessments, and communicate effectively both verbally and in writing
Demonstrated ability to establish effective scientific partnerships with key stakeholders
Working knowledge of GCP, clinical trial design,